Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Structure and dynamics of the epidermal growth factor receptor C-terminal phosphorylation domain.

Lee NY, Hazlett TL, Koland JG.

Protein Sci. 2006 May;15(5):1142-52. Epub 2006 Apr 5.

3.

Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation.

Thiel KW, Carpenter G.

Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19238-43. Epub 2007 Nov 27.

4.
5.

Affibody-mediated retention of the epidermal growth factor receptor in the secretory compartments leads to inhibition of phosphorylation in the kinase domain.

Vernet E, Lundberg E, Friedman M, Rigamonti N, Klausing S, Nygren PA, Gräslund T.

N Biotechnol. 2009 Sep;25(6):417-23. doi: 10.1016/j.nbt.2009.02.001.

PMID:
19552886
6.

Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells.

Yamamoto N, Mammadova G, Song RX, Fukami Y, Sato K.

J Cell Sci. 2006 Nov 15;119(Pt 22):4623-33. Epub 2006 Oct 24.

7.

UV-radiation-induced internalization of the epidermal growth factor receptor requires distinct serine and tyrosine residues in the cytoplasmic carboxy-terminal domain.

Oksvold MP, Thien CB, Widerberg J, Chantry A, Huitfeldt HS, Langdon WY.

Radiat Res. 2004 Jun;161(6):685-91.

PMID:
15161351
8.

Tyrosine kinase activity of epidermal growth factor receptor is regulated by GM3 binding through carbohydrate to carbohydrate interactions.

Kawashima N, Yoon SJ, Itoh K, Nakayama K.

J Biol Chem. 2009 Mar 6;284(10):6147-55. doi: 10.1074/jbc.M808171200. Epub 2009 Jan 5.

9.
10.

Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.

Huang Y, Li X, Jiang J, Frank SJ.

Oncogene. 2006 Dec 7;25(58):7565-76. Epub 2006 Jun 19.

PMID:
16785991
11.

Epidermal growth factor receptor phosphorylation sites Ser991 and Tyr998 are implicated in the regulation of receptor endocytosis and phosphorylations at Ser1039 and Thr1041.

Tong J, Taylor P, Peterman SM, Prakash A, Moran MF.

Mol Cell Proteomics. 2009 Sep;8(9):2131-44. doi: 10.1074/mcp.M900148-MCP200. Epub 2009 Jun 15.

12.

Structure of the membrane reconstituted transmembrane-juxtamembrane peptide EGFR(622-660) and its interaction with Ca2+/calmodulin.

Sato T, Pallavi P, Golebiewska U, McLaughlin S, Smith SO.

Biochemistry. 2006 Oct 24;45(42):12704-14.

PMID:
17042488
13.
14.
15.

S-Nitrosylation of the epidermal growth factor receptor: a regulatory mechanism of receptor tyrosine kinase activity.

Murillo-Carretero M, Torroglosa A, Castro C, Villalobo A, Estrada C.

Free Radic Biol Med. 2009 Feb 15;46(4):471-9. doi: 10.1016/j.freeradbiomed.2008.10.048. Epub 2008 Nov 11.

PMID:
19056486
16.

Alpha 1,3-fucosyltransferase-VII regulates the signaling molecules of the insulin receptor pathway.

Wang QY, Zhang Y, Chen HJ, Shen ZH, Chen HL.

FEBS J. 2007 Jan;274(2):526-38.

18.

Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.

Yi T, Lee HL, Cha JH, Ko SI, Kim HJ, Shin HI, Woo KM, Ryoo HM, Kim GS, Baek JH.

J Cell Physiol. 2008 Nov;217(2):409-22. doi: 10.1002/jcp.21511.

PMID:
18543257
19.

Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside.

Wang XQ, Yan Q, Sun P, Liu JW, Go L, McDaniel SM, Paller AS.

Cancer Res. 2007 Oct 15;67(20):9986-95.

20.

Role of conformational alteration in the epidermal growth factor receptor (EGFR) function.

Bishayee S.

Biochem Pharmacol. 2000 Oct 15;60(8):1217-23. Review.

PMID:
11007960

Supplemental Content

Support Center